EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
7.10
-0.02 (-0.28%)
Dec 20, 2024, 4:00 PM EST - Market closed

EyePoint Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
4981,088119415100168
Upgrade
Market Cap Growth
52.98%811.96%-71.25%316.71%-40.59%-6.64%
Upgrade
Enterprise Value
2679588334125186
Upgrade
Last Close Price
7.1023.113.5012.246.5815.50
Upgrade
PS Ratio
7.8723.642.8811.232.898.23
Upgrade
PB Ratio
1.744.081.242.255.3720.12
Upgrade
P/TBV Ratio
1.954.081.242.57--
Upgrade
P/OCF Ratio
-580.20----
Upgrade
EV/Sales Ratio
5.8520.820.209.053.629.14
Upgrade
Debt / Equity Ratio
0.110.020.480.212.216.07
Upgrade
Asset Turnover
0.200.170.190.210.420.27
Upgrade
Inventory Turnover
29.8520.3217.838.066.2214.94
Upgrade
Quick Ratio
5.215.254.639.723.652.92
Upgrade
Current Ratio
5.505.455.0010.054.243.62
Upgrade
Return on Equity (ROE)
-74.68%-39.04%-72.84%-57.58%-337.87%-247.12%
Upgrade
Return on Assets (ROA)
-31.39%-17.24%-22.24%-19.46%-28.30%-39.58%
Upgrade
Return on Capital (ROIC)
-47.18%-22.28%-26.94%-24.40%-39.32%-52.39%
Upgrade
Earnings Yield
-20.79%-6.51%-85.72%-14.08%-45.60%-33.89%
Upgrade
FCF Yield
-23.70%-0.15%-56.30%-12.11%-14.86%-33.96%
Upgrade
Buyback Yield / Dilution
-34.50%-4.25%-29.76%-124.04%-23.06%-53.88%
Upgrade
Total Shareholder Return
-34.50%-4.25%-29.76%-124.04%-23.06%-53.88%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.